-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Announces Substantial Increase in Number of Insertions
Kraig Biocraft Laboratories, Inc. was pleased to announce this morning that during the months of May, June and July the scientific team achieved its previously announced goal to significantly ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. However, the actual number of insertions performed greatly exceeded that goal and the increase was sustained in June and July as well.
“Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period,” stated CEO Kim K. Thompson. “This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”
-
Kraig Biocraft Laboratories Inc.’s (KBLB.OB) Unique Corporate Goals
Kraig Biocraft Laboratories Inc. is a cutting edge biotechnology company that is focused on the development of high performance fibers and polymers by creating transgenic silkworms inserted with spider genes. The goal is that these transgenic silkworms will spin a new “super fiber” similar to natural spider silk.
Spider silk is one of the strongest and most resilient fibers known. It has several properties that are unmatched by synthetic fibers. One property is spider silk’s ability to absorb energy and then dissipate the energy evenly. Another property is spider silk’s extreme resistance to breaking under strain. In this respect, spider silk outperforms all known fibers – natural and man-made. It is these properties that make spider silk especially attractive in applications for use in products such as bulletproof vests, artificial limbs, suspension cables and parachute cords.
Kraig Biocraft has acquired the exclusive rights to the genetic sequences for spiders patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working together with the leading genetic engineers at these universities to develop enzymes and strategies for conducting site specific genetic recombination of the spider silk gene in an effort to produce a transgenic variety of silkworm.
Efforts to produce the desired proteins in a transgenic silkworm have significantly accelerated during the course of the year, possibly leading to a breakthrough by the end of 2009. Kraig Biocraft has been able to make 5000+ insertions of genetic packets per week. The company reached a milestone in May with the announcement of the creation of eight spider silk-based genetic constructs. The genetic constructs are packets of DNA that act as a blueprint for the creation of new polymers and spider silk-based proteins.
If Kraig Biocraft is successful in creating a spider silk-based fiber product, the company will be breaking into the huge $90 billion global market for high performance technical fibers. The United States market (where Kraig Biocraft will have their patents) for these fibers is roughly $45 billion. This industry has experienced significant growth over the past decade and growth is expected to continue in the industry for the foreseeable future.
Estimates have been made that any product produced by the company should immediately be worth several hundred dollars in revenues. Spider silk’s unqiue advantages – resistance to breakage and energy absorption – along with the fact that it is a natural product and not produced using toxic chemicals should allow Kraig Biocraft to easily find a profitable niche within the massive fibers industry.
-
This may be a nice product but when is this stock finally moving higher?
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Very Pleased With its Progress
Kraig Biocraft Laboratories, Inc., the Michigan-based company pioneering the use of genetic engineering to produce spider silk, recently announced that, during the months of May, June, and July, their scientific team succeeded in its goal to scale up the number of genetic insertions performed. The company has developed an efficient way to insert into silkworms the genetic material used by spiders to produce silk, with the goal of getting silkworms to produce commercially viable spider silk.
The team, led by Malcolm J. Fraser, Ph.D., had an initial goal of doubling the number of DNA construct insertions performed in May. As it turned out, the actual number of insertions performed greatly exceeded that goal, and the increase was sustained in June and July as well. Dr. Fraser heads the Fraser Laboratory at the University of Notre Dame where much of the research is being done.
Kraig’s CEO, Kim Thompson, commented on the unexpected achievement. “Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period. This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”
Since Kraig Biocraft first obtained the right to use the spider silk gene sequence in this particular field of research, they have significantly improved the insertion process. Their approach is a unique protein expression system that is potentially highly scalable and cost effective in producing a variety of proteins that can be marketed to the pharmaceutical and fibers markets, although spider silk remains the primary goal of the company. The company has successfully inserted into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk, but work remains to be done for the actual commercial production of spider silk.
Spider silk is, by weight, much stronger than steel, with a much greater ability to absorb and dissipate energy. This strength to weight ratio promises a wide range of applications, and a huge commercial market.
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) on the Verge of Unlocking New Markets
Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.
Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.
Kraig Biocraft has acquired the exclusive US rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is working directly in conjunction with leading genetic engineers at these universities to develop transgenic silkworms.
Kraig Biocraft’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. The company expects this intellectual property portfolio to expand over the coming years.
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) is Excited about Spider Silk
Kraig Biocraft Laboratories Inc. is an emerging biotech company with a strong intellectual property portfolio relating to genetic modification of silkworms to produce spider silk. The company believes this path of research will lead to the development of a new “super fiber” such as Kevlar. The total market for such fibers is believed to be about $90 billion annually.
Kraig Biocraft has reason to be excited about spider silk. The silk produced by spiders is among the strongest fibers produced in nature. Spider silk is also extremely elastic and resilient. Depending upon how measurements are made, spider silk is nearly as strong, or in some cases even stronger, than steel or Kevlar.
Spider silk has several properties that are unmatched even by the most exotic of man-made fibers. Spider silk has the unbeatable capacity to absorb energy and to dissipate this energy in a very controlled manner. This unique property makes this fiber especially attractive for applications where energy absorption is a key design factor.
Another significant property of spider silk is its extreme resistance to breaking under strain. In this area, it outperforms virtually ALL known natural and synthetic fibers. If Kraig Biocraft’s research is successful and they are able to produce a spider silk product, it may well be a real money-maker for the company. Estimates are that such a product may immediately be worth from several hundred million dollars to as high as one billion dollars. A 2% penetration of the “super fiber” market would likely be worth in excess of $3 billion.
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Continues To Grow Its Intellectual Property Portfolio
Kraig Biocraft Laboratories, Inc., the Michigan-based company using genetic engineering to allow silkworms to produce spider silk, is making use of some of the most advanced insect-related genetic engineering techniques known. Scientists have already produced the first transgenic silkworms, and other scientists have discovered the sequence of genes used by spiders to produce silk. The brilliance of Kraig’s approach is the bringing together of researchers from both of these fields in a collaborative effort to produce commercially viable quantities of spider silk.
Kraig Biocraft has acquired the exclusive rights in this field to the genetic sequences patented by the University of Wyoming, and the genetic engineering technology developed by the University of Notre Dame. The company is now working in conjunction with the leading genetic scientists at these universities to produce a transgenic variety of silkworm capable of producing the elusive spider silk.
The process is tedious and exacting, but the goal could be worth tens of billions of dollars. Spider silk exceeds all known fibers in its ability to absorb energy without breaking. This makes it a potential super fiber for a host of ballistic resistant, medical, industrial, and even fashion related applications. Discovering a way to make such silk commercially viable would be a major scientific achievement, of exceeding value to companies like DuPont that currently dominate the technical textiles market.
As part of the company’s intellectual property portfolio, Kraig Biocraft has the exclusive rights to use the patented spider silk gene sequences in silkworms within the United States. The company’s intellectual property portfolio also includes a separate U.S. provisional patent application for certain methodologies, genetic sequences, organic polymers, and composites of fibers.
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Focused on Entering the $92 Billion Market for High-Performance and Technical Fibers
Kraig Biocraft Laboratories, Inc., a biotechnology company focused on the development of commercially significant polymers and high performance fibers, invests in genetic research and targeted product development to create innovative near-term solutions to meet the practical problems of our world. The company is currently working in cooperation with university scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace for high-performance polymers.
Kraig Biocraft Laboratories develops collaborative relationships with leading universities and funds university scientists and laboratories to create technologies with significant commercial applications through the Kraig Research Initiative. As a part of this program, the company has licensed university intellectual property in the fields of genetics and genetic engineering.
The company sponsors and collaborates on research within various universities’ genetic engineering laboratories. In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time, the company has been a proud sponsor of scientific research and development within the university.
-
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Exceeds Goal for DNA Insertions
Kraig Biocraft Laboratories Inc. is a biotech company working to develop and commercialize high performance polymers. The company intends to break into the $92 billion market for high performance fibers by using spider silk genes.
The company intends to insert these genes into silkworms to make them produce fibers with the characteristics of spider silk, which is one of the strongest natural fibers known. In an effort to reach these goals, Kraig Biocraft has licensed the spider gene sequences patented by the University of Wyoming and the genetic developed technology by the University of Notre Dame.
Several weeks ago, Kraig Biocraft announced that during the months of May, June and July the scientific team succeeded in its previously announced attempt to ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. In May itself, the rate of DNA construct insertions were twice the number of insertions that had been performed to date.
The genetic constructs are DNA packets that act as a blueprint for the creations of new polymers and proteins based on spider silk. Every targeted DNA construct insertion has the potential to create a new fiber with commercial applications. Kraig Biocraft was very pleased to report that the actual number of insertions performed greatly exceeded the company’s target and that the increase in insertions was sustained through the months of June and July as well.
Kraig Biocraft CEO Kim K. Thompson commented on the success of the company’s scientific team, which is led by Dr. Malcolm J. Fraser. He said, “Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period. This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists.”
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Visit Homepage
Reply With Quote
Posting Permissions
Bookmarks